We have established that Treg cells expressing TCRs shared with effector CD4+ T cells constitute about half of all Treg cells in the tumor site while in unmanipulated mice they account for only 10-15% of all Treg cells (Fig. 5C)[20]. This evidence concerns the gene CD4 and neoplasm.